openPR Logo
Press release

Osteosynthesis Devices Market Report: 2023 Edition with leading Players

03-16-2017 02:34 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Osteosynthesis Devices Market Report: 2023 Edition with

Osteosynthesis Devices Market

The key factor responsible for the rising demand for osteosynthesis devices is the growing prevalence of osteoarthritis and osteoporosis. Both medical issues have a considerable public health burden as they occur commonly among the geriatric population around the world. The rise in the number of patients suffering from these conditions is directly related to the growing population of the elderly. Osteoarthritis, termed by major medical organizations as one of the leading disabling diseases in developed countries, can add severe limitations to the movement and mobility of a patient. Therefore, treatment of the disease is pertinent to the overall geriatric demographic wellbeing.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5981

Outside of the elderly population, there are several factors that drastically increase the chances of a patient suffering from osteoarthritis, including obesity and physical injuries. As such, a rise in the number of obese people, especially in developed nations, is a highly concerning factor for healthcare agencies and a major driver for the production and development of osteosynthesis devices. The number of road accidents and sports injuries is also increasing around the world, adding to the probability of an increase in the demand for osteosynthesis devices in the coming years.

Osteosynthesis devices, however, have quite often been subject to product recalls in recent past, severely reducing their overall usability and market growth.

A culmination of the above factors along with other minor drivers and restraints is likely to result in a CAGR of 6.5% for the global osteosynthesis devices market revenue from 2015 to 2023. By the end of 2016, this revenue is expected to reach US$6.69 bn, and US$11.09 bn by the end of 2023.

North America Demand for Osteosynthesis Devices Soars as Elderly Population Increases

By the end of 2023, the revenue generated from North America by manufacturers of osteosynthesis devices is expected to reach US$4.7 bn. This falls in place with the consistent dominance shown by the region in terms of demand. The key reason for this high demand is the large number of geriatrics in the region. Additionally, the large presence of key players and the high investments in osteosynthesis by governments have also added to the growth in demand for osteosynthesis devices in the region. Osteosynthesis devices are mostly available at premium prices in both North America and Europe. This has not deterred purchasers as the use of premium osteosynthesis devices provides a higher level of treatments to be made available for a problem that is already exceedingly high in priority.

Meanwhile, Asia Pacific is showing a significantly high demand for osteosynthesis devices, owing to a high population density and a rapidly increasing healthcare infrastructure and reach. This region’s revenue from osteosynthesis devices is expanding at a CAGR of 8.3% from 2015 to 2023. It is therefore considered as the most lucrative region by key players.

Non-degradable Materials Continue Dominating Market Demand

Degradable and non-degradable are the two major types of material categories in use to make osteosynthesis devices. Of these, non-degradable materials already have a long history of use in osteosynthesis devices and orthopedic implants. They are most commonly inclusive of cobalt-chromium alloys, stainless steels, and titanium. At the moment, the overall growth rate and demand for non-degradable osteosynthesis devices is quite high, owing to the utility-based advantages they provide. Titanium, for instance, is considered as the most biocompatible metal and offers high indices of elasticity, strength, and corrosion resistance.

However, non-degradable devices are connected to a higher rate of transmitting infections, thus complicating a patient’s health and increasing the chances for a second surgery. As a result, larger healthcare organizations are pushing for the use of degradable osteosynthesis devices that offer a one-time use and therefore considerably reduce the chances of infections. The future of osteosynthesis devices could very well be based in the development of degradable materials.

Browse Market Research Report @ http://www.transparencymarketresearch.com/osteosynthesis-devices-market.html

The key manufacturers of osteosynthesis devices across the world include DePuy Synthes, Zimmer Biomet, Stryker Corporation, Smith & Nephew, Neosteo SAS, and Aesculap, Inc.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteosynthesis Devices Market Report: 2023 Edition with leading Players here

News-ID: 470079 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Osteosynthesis

Spinal Osteosynthesis Units Market 2022 | Detailed Report
The Spinal Osteosynthesis Units research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Spinal Osteosynthesis Units research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force. Download FREE Sample Report
Osteosynthesis Devices Market Research Report Forecast to 2023
The research report reveals that the global market for osteosynthesis devices is expected to reach US$11 bn by the end of 2023, after expanding at a CAGR of 6.5% from 2015 to 2023 in revenue. This revenue was slated to go over US$6.6 bn in 2016. Asia Pacific is expected to be an attractive region for the supply of osteosynthesis devices over the coming years, due to a swiftly evolving
Osteosynthesis Devices Market: Regional & Competitive Analysis
The research report reveals that the global market for osteosynthesis devices is expected to reach US$11 bn by the end of 2023, after expanding at a CAGR of 6.5% from 2015 to 2023 in revenue. This revenue was slated to go over US$6.6 bn in 2016. Asia Pacific is expected to be an attractive region for the supply of osteosynthesis devices over the coming years, due to a swiftly evolving
Osteosynthesis Device Market: Opportunities and Forecasts, 2023
DePuy Synthes, Stryker Corporation, and Zimmer Biomet were the three leading players in the global osteosynthesis devices market in 2014. Their collective share in the market stood at 83.7%, indicating an extremely consolidated market. The leading players have established domination in the market through a massive product portfolio along with a string of successful mergers and acquisitions, such as the merger of Johnson & Johnson or DePuy with Synthes to
Osteosynthesis Devices Market: Global Markets & Advanced Technologies
DePuy Synthes, Stryker Corporation, and Zimmer Biomet were the three leading players in the global osteosynthesis devices market in 2014. Their collective share in the market stood at 83.7%, indicating an extremely consolidated market. The leading players have established domination in the market through a massive product portfolio along with a string of successful mergers and acquisitions, such as the merger of Johnson & Johnson or DePuy with Synthes to
Osteosynthesis Devices Market Forecast to 2022
Osteosynthesis devices such as metal plates, nails and screws are used scientifically to repair the bone through inter-fragmental compression and achieve fracture union. These devices help in eliminating the need for plaster cast or skeletal traction and reduce patient stay in hospitals. The global osteosynthesis devices market is expected to grow at a healthy rate over the next five years, due to the rapid rise in demand from different parts